Recent Press Releases

CAS and AstraZeneca Agree to Five-Year SciFinder® Contract

COLUMBUS, Ohio -- Chemical Abstracts Service (CAS), the world's authority for chemical information, announced today a landmark five-year agreement for SciFinder®, the choice for chemistry...

Accelovance Continues Expansion with Opening of Research Triangle Park, North Carolina Office

ROCKVILLE, Md. -- Accelovance, a therapeutically focused clinical research organization (CRO), announced today the opening of a new office in Research Triangle Park (RTP), North Carolina. This office...

Cinven to invest in Medpace

Strong growth drivers in CRO market European private equity firm, Cinven, today announces a majority investment in Medpace, Inc. ('Medpace' or 'the Group'), a leading contract...

PPD and Charité–Universitätsmedizin Berlin Announce Strategic Collaboration to Expand Clinical Research in Germany

WILMINGTON, N.C. & BERLIN--()--Pharmaceutical Product Development, LLC (PPD) and the Charité–Universitätsmedizin Berlin today announced a new collaboration between...

Global Genomics Group And Quintiles, Inc. Collaborate On Cross-Functional Pan-Omic Study Of Biomarkers And Drug Target Discovery For Cardiovascular Diseases

February 19, 2014 -- Global Genomics Group (G3) and Quintiles today announced that they will collaborate to investigate novel biomarkers and biological pathways for use in the development of...

Charles River Laboratories launches RightSourceSM insourcing service for biotech and pharma companies

New service will enable companies to completely externalize their biologic quality control (QC) testing program to Charles River WILMINGTON, Mass. Feb. 18, 2014 - As pharma and biotech companies race...

PAREXEL LAUNCHES NEW REGULATORY OUTSOURCING SERVICE LINE

Company broadens portfolio of regulatory information management solutions to enhance client value Boston, MA, February 19, 2014 — PAREXEL International Corporation (NASDAQ: PRXL), a leading...

ICON Reports Fourth Quarter 2013 Revenue of $345 million, up 15% year on year and EPS of 53c, up 56% year on year. Full Year 2013 Revenue was $1.34 billion, up 20% year on year, EPS was $1.77 up 77% year on year. Guidance issued for 2014.

Highlights – Fourth Quarter and Full year ended December 31, 2013. Quarter 4 net revenue increased 15% year on year to $345 million. Full Year 2013 net revenue increased 20% to $1.34...

Phosphate Therapeutics Selects Clinipace Worldwide to Manage its Phase 2 Renal Study

MORRISVILLE, N.C.--()--Clinipace Worldwide, a global digital clinical research organization (dCRO), announced today that Phosphate Therapeutics, co-owned and resourced by Shield...

DaVita Clinical Research and Pyxant Labs to Collaborate on Clinical Trials

MINNEAPOLIS, Feb. 12, 2014 /PRNewswire-USNewswire/ -- DaVita Clinical Research® (DCR®), a specialty contract research organization with services spanning the full spectrum of drug and device...

Theorem Clinical Research and Decision Driver Analytics Form Strategic Alliance

KING OF PRUSSIA, Pa.--()--Theorem Clinical Research has announced the formation of a strategic alliance with Decision Driver Analytics (DDA) that will integrate health economics and...

Chiltern Partners With Karolinska Development

LONDON and WILMINGTON, N.C., Feb. 12, 2014 /PRNewswire/ -- Chiltern International Limited (Chiltern), a global contract research organization (CRO), proudly announces our partnership with Karolinska...

Quintiles Reports Fourth Quarter 2013 Results

$1.0 billion of service revenues in the fourth quarter; First billion dollar service revenue quarter in Quintiles' history Net new business wins of $1.3 billion representing a book-to-bill...

AMRI Announces Fourth Quarter and Full Year 2013 Results and Provides 2014 Guidance

ALBANY, N.Y., Feb. 12, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today reported financial and operating results for the fourth quarter and full year ended December 31, 2013. Fourth Quarter and Full...

PAREXEL Rebrands Its Technology Subsidiary PAREXEL Informatics; Retains Perceptive Brand For Service Offerings

BOSTON, Feb. 12, 2014 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that Perceptive Informatics, the PAREXEL...

PAREXEL Simplifies Drug Development Journey From Science To New Treatments

Boston, MA, February 12, 2014 — As the global biopharmaceutical industry increasingly seeks to streamline the complex process of bringing new drugs to market, PAREXEL International Corporation...

Charles River Laboratories Announces Fourth-Quarter and Full-Year 2013 Results from Continuing Operations and Provides 2014 Guidance

– Fourth-Quarter Sales of $289.2 Million and Full-Year 2013 Sales of $1.17 Billion – – Fourth-Quarter GAAP Earnings per Share of $0.40 and Non-GAAP Earnings per Share of $0.73...